Indirect protection of adults from rotavirus by pediatric rotavirus vaccination

Clinical Infectious Diseases

Volumn 56, Issue 6, 2013, Pages 755-760

  Anderson, Evan J ^a,b,c,d   Shippee, Deanna B ^a,c   Weinrobe, Melissa H ^a,b,c,d   Davila, Melissa D ^b,d   Katz, Ben Z ^a,c   Reddy, Susheel ^b,d   Cuyugan, Mary Gene Karen P ^a,c   Lee, Samuel Y ^a,c   Simons, Yael M ^a,c   Yogev, Ram ^a,c   Noskin, Gary A ^b,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

adult; genotypes; indirect protection; pediatric; rotavirus

Indexed keywords

NITAZOXANIDE; ROTAVIRUS VACCINE;

ADULT; ARTICLE; BACTERIAL STOOL CULTURE; CLOSTRIDIUM DIFFICILE INFECTION; CRYPTOSPORIDIOSIS; ENZYME IMMUNOASSAY; FECES CULTURE; GENOTYPE; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; ROTAVIRUS INFECTION; VACCINATION; VIRUS ISOLATION;

ADOLESCENT; ADULT; CHICAGO; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RNA, VIRAL; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION; YOUNG ADULT;

EID: 84874780400     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis1010     Document Type: Article

References (30)

1. Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis 2011; 43:683-9.
2. Perdue DG, Bulkow LR, Gellin BG, et al. Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. JAMA 2000; 283:3089-94.
3. Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354:1455-63.
4. Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006; 368:323-32.
5. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136-41.
6. Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis 2008; 8:642-9.
7. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996; 335:1022-8.
8. Anderson EJ, Weber SG. Rotavirus infection in adults. Lancet Infect Dis 2004; 4:91-9.
9. Anderson EJ, Katz BZ, Polin JA, Reddy S, Weinrobe MH, Noskin GA. Rotavirus in adults requiring hospitalization. J Infect 2012; 64:89-95.
10. Anderson EJ, Rupp A, Shulman ST, Wang D, Zheng X, Noskin GA. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children. Pediatrics 2011; 127:e264-70.
11. Tate JE, Panozzo CA, Payne DC, et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009; 124:465-71.
12. Payne DC, Staat MA, Edwards KM, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis 2011; 53:245-53.
13. Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011; 204:980-6.
14. Cortes JE, Curns AT, Tate JE, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011; 365:1108-17.
15. Lopman BA, Hall AJ, Curns AT, Parashar UD. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis 2011; 52:466-74.
16. Bresee JS, Marcus R, Venezia RA, et al. The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States. J Infect Dis 2012; 205:1374-81.
17. Anderson EJ, Reddy S, Katz BZ, Noskin GA. Indirect protection and indirect measures of protection from rotavirus in adults. J Infect Dis 2012; 205:1762-4.
18. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32: 331-51.
19. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63.
20. Linhares AC, Velazquez FR, Perez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371:1181-9.
21. DiStefano DJ, Kraiouchkine N, Mallette L, et al. Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis. J Clin Microbiol 2005; 43:5876-80.
22. Yen C, Jakob K, Esona MD, et al. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine 2011; 29:4151-5.
23. Pitzer VE, Viboud C, Simonsen L, et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science 2009; 325:290-4.
24. Notes from the field: outbreaks of rotavirus gastroenteritis among elderly adults in two retirement communities - Illinois, 2011. MMWR 2011; 60:1456.
25. Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007; 119:684-97.
26. Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010; 126: e506-12.
27. Hull JJ, Teel EN, Kerin TK, et al. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011; 30:S42-7.
28. Rahman M, Matthijnssens J, Yang X, et al. Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol 2007; 81:2382-90.
29. Freeman MM, Kerin T, Hull J, et al. Phylogenetic analysis of novel G12 rotaviruses in the United States: A molecular search for the origin of a new strain. J Med Virol 2009; 81:736-46.
30. Curns AT, Panozzo CA, Tate JE, et al. Remarkable postvaccination spatiotemporal changes in United States rotavirus activity. Pediatr Infect Dis J 2011; 30: S54-5.